Articles with public access mandates - Stephen Q WongLearn more
Not available anywhere: 7
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
R Agarwal, YC Chan, CS Tam, T Hunter, D Vassiliadis, CE Teh, ...
Nature medicine 25 (1), 119-129, 2019
Mandates: Swiss National Science Foundation, Howard Hughes Medical Institute, National …
Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver
C Emmanuel, YE Chiew, J George, D Etemadmoghadam, MS Anglesio, ...
Clinical cancer research 20 (24), 6618-6630, 2014
Mandates: National Health and Medical Research Council, Australia
Longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors
JH Lee, AM Menzies, MS Carlino, AC McEvoy, S Sandhu, AM Weppler, ...
Clinical Cancer Research 26 (15), 4064-4071, 2020
Mandates: National Health and Medical Research Council, Australia
Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma
VJ Mar, SQ Wong, A Logan, T Nguyen, J Cebon, JW Kelly, R Wolfe, ...
Pigment cell & melanoma research 27 (6), 1117-1125, 2014
Mandates: National Health and Medical Research Council, Australia
The role of BRAF mutations in primary melanoma growth rate and survival
VJ Mar, W Liu, B Devitt, SQ Wong, A Dobrovic, GA McArthur, R Wolfe, ...
British Journal of Dermatology 173 (1), 76-82, 2015
Mandates: National Health and Medical Research Council, Australia
Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations
AJ Colebatch, T Witkowski, PM Waring, GA McArthur, SQ Wong, ...
Clinical chemistry 64 (4), 745-747, 2018
Mandates: National Health and Medical Research Council, Australia
Clinical validation and implementation of droplet digital PCR for the detection of BRAF mutations from cell-free DNA
R Arnolda, K Howlett, T Chan, J Raleigh, A Hatzimihalis, A Bell, ...
Pathology 54 (6), 772-778, 2022
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 39
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer
ML Burr, CE Sparbier, KL Chan, YC Chan, A Kersbergen, EYN Lam, ...
Cancer cell 36 (4), 385-401. e8, 2019
Mandates: Howard Hughes Medical Institute, National Health and Medical Research …
UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas
SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ...
Cancer research 75 (24), 5228-5234, 2015
Mandates: National Health and Medical Research Council, Australia
RET solvent front mutations mediate acquired resistance to selective RET inhibition in RET-driven malignancies
BJ Solomon, L Tan, JJ Lin, SQ Wong, S Hollizeck, K Ebata, BB Tuch, ...
Journal of Thoracic Oncology 15 (4), 541-549, 2020
Mandates: US National Institutes of Health
BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage
VJ Mar, SQ Wong, J Li, RA Scolyer, C McLean, AT Papenfuss, RW Tothill, ...
Clinical Cancer Research 19 (17), 4589-4598, 2013
Mandates: National Health and Medical Research Council, Australia
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA
L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, ...
Annals of Oncology 30 (5), 804-814, 2019
Mandates: National Health and Medical Research Council, Australia, Cancer Research UK …
Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates
H Do, SQ Wong, J Li, A Dobrovic
Clinical chemistry 59 (9), 1376-1383, 2013
Mandates: National Health and Medical Research Council, Australia
Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma
SQ Wong, JM Raleigh, J Callahan, IA Vergara, S Ftouni, A Hatzimihalis, ...
JCO Precision Oncology 1, 1-14, 2017
Mandates: National Health and Medical Research Council, Australia
Patient-derived models of abiraterone-and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy
MG Lawrence, D Obinata, S Sandhu, LA Selth, SQ Wong, LH Porter, ...
European urology 74 (5), 562-572, 2018
Mandates: US National Institutes of Health, National Health and Medical Research …
Role of p53 in the progression of gastric cancer
RA Busuttil, GV Zapparoli, S Haupt, C Fennell, SQ Wong, JMB Pang, ...
Oncotarget 5 (23), 12016, 2014
Mandates: National Health and Medical Research Council, Australia
Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia
P Yeh, T Hunter, D Sinha, S Ftouni, E Wallach, D Jiang, YC Chan, ...
Nature communications 8 (1), 14756, 2017
Mandates: National Health and Medical Research Council, Australia
Genome-wide plasma DNA methylation features of metastatic prostate cancer
A Wu, P Cremaschi, D Wetterskog, V Conteduca, GM Franceschini, ...
The Journal of clinical investigation 130 (4), 1991-2000, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort
G Mitchell, ML Ballinger, S Wong, C Hewitt, P James, MA Young, ...
PloS one 8 (7), e69026, 2013
Mandates: National Health and Medical Research Council, Australia
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes
P Yeh, M Dickinson, S Ftouni, T Hunter, D Sinha, SQ Wong, R Agarwal, ...
Blood, The Journal of the American Society of Hematology 129 (12), 1685-1690, 2017
Mandates: National Health and Medical Research Council, Australia
Publication and funding information is determined automatically by a computer program